USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bauerfeind AG

USPTO PatentsView assignee record - 59 granted patents across 19 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Bauerfeind ranks #5,740 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 19 technology areas.

#5,740
of 49,997 US assignees by volume
Top 41%
by Innovation Score (38.4/100)
7.8
avg claims per patent
+52%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5740 · Foreign Corporation #5,740 · 59 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 59 grants
  • UPPER-Q #5,740/49,997
  • PHOTO-FINISH Accuvein
  • CPC-FOCUS A61F · 19 areas
  • INNOV-THIN 38.4/100
  • CLAIMS-SPARSE 7.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +52% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Accuvein, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bauerfeind’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bauerfeind

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bauerfeind's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bauerfeind?

Each dot is one of Bauerfeind’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bauerfeind’s own 7.8 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bauerfeind vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 58.959.059.05959.059.059.1 510152025 Granted patents (volume) Avg claims / patent Arris Technology, Inc. - 59, 16.17Arris TechnologyAuras Technology Co., Ltd. - 59, 12.49Auras TechnologyAccuvein, Inc. - 59, 15.9AccuveinAerin Medical Inc. - 59, 13.75Aerin MedicalBaylor Research Institute - 59, 14.32Baylor Research I…BP Exploration Operating Company Limited - 59, 21.85BP Exploration Op…Banjo Corporation - 59, 19.64BanjoBlueprint Medicines Corporation - 59, 17.17Blueprint Medicin…Bauerfeind AG - 59, 7.85Bauerfeind
Bauerfeind vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bauerfeind's grants concentrate

Bauerfeind AG is a focused PatentsView assignee: 19 CPC subclasses with 45.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (13 grants) versus a trough of 1 in 2018. By volume, Bauerfeind sits between Arris Technology, Inc. and Blueprint Medicines Corporation.

Bauerfeind's three-year grant acceleration

From 2019–2021 to 2022–2024, Bauerfeind AG moved from 26 to 16 grants (0.61x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Bauerfeind's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Bauerfeind holds 59 patents at rank #5,739, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Bauerfeind

By rank, the assignees closest to #5,739 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Bauerfeind's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bauerfeind, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Bauerfeind ranks #238 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Similar claim depth

Nearest assignees by average claims per patent (7.8 here).

Bauerfeind's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20152016201720182019202020212022202320242025 6
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Bauerfeind AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 6.8%
2016 2 3.4%
2017 4 6.8%
2018 1 1.7%
2019 10 16.9%
2020 13 22.0%
2021 3 5.1%
2022 5 8.5%
2023 8 13.6%
2024 3 5.1%
2025partial year 6 10.2%

Which technologies does Bauerfeind AG patent most?

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Bauerfeind AG's patent record in context - here's where to go next.

  • Bauerfeind AG's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 45.8% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #5,740 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Bauerfeind AG against Arris Technology, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.